STD Diagnostics Market Growth: Market Analysis and Insights
The STD Diagnostics Market size was valued at USD 91442.1 million in 2022 and is expected to grow to USD 142477.44 million by 2030 and grow at a CAGR of 5.7 % over the forecast period of 2023-2030.
The STD diagnostics market is a rapidly growing sector within the
healthcare industry. With the increasing prevalence of sexually transmitted
diseases worldwide, there is a rising demand for accurate and efficient
diagnostic tools and tests.
One of the key factors driving the growth of this market is the
growing awareness about sexually transmitted infections (STIs) and their
potential health risks. Governments, healthcare organizations, and non-profit
entities are actively promoting education and awareness campaigns to encourage
individuals to get tested regularly. This has led to an increased number of
people seeking diagnostic services, thereby fueling market growth.
Get Free Sample Report @ https://www.snsinsider.com/sample-request/2995
Advancements in technology have also played a significant role in
shaping the STD diagnostics market. Traditional methods of testing, such as
culture-based techniques, are being replaced by more sensitive and specific
molecular diagnostic tests like polymerase chain reaction (PCR) and nucleic
acid amplification tests (NAATs). These newer methods offer faster results with
higher accuracy, enabling early detection and timely treatment.
Key
Market Segmentation:
By Type
- Chlamydia testing
- Syphilis testing
- Gonorrhea testing
- Herpes Simplex Virus testing
- Human Papilloma Virus testing
- Human Immunodeficiency Virus testing
- Chancroid testing
- Others
By Location of Testing
- Laboratory Testing
- Commercial/Private labs
- Public Health Labs
- Point of Care (PoC) testing
By Testing Device
Devices
- Thermal Cyclers - PCR
- Absorbance microplate reader - Enzyme-Linked
Immunosorbent Assay (ELISA)
- Differential Light Scattering machines
- Flow Cytometers
- Lateral Flow Readers - Immunochromatographic
assays
- Others
Point of Care (PoC) Devices
- Phone chips (microfluidics + ICT)
- Portable/benchtop/rapid diagnostic kits
Key
players
The major Key players are Abbott Laboratories (US),F. Hoffmann-La
Roche Ltd. (Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc.
(US), Danaher Corporation (US), Quide! Corporation(US), Hologic, Inc. (US),
Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), DiaSorin S.p.A (Italy), Grifols S.A. (Spain)
and other players listed in the final report.
Other
Report
Opioid
Use Disorder (OUD) Market Growth
About
US:
SNS
Insider has been a leader in data and analytics globally with its authentic
consumer and market insights. The trust of our clients and business partners
has always been at the center of who we are as a company. We are a business
that leads the industry in innovation, and to support the success of our
clients, our highly skilled engineers, consultants, and data scientists have
consistently pushed the limits of the industry with innovative methodology and
measuring technologies.
We
assist our clients to anticipate industrial, economic, and consumer trends to
drive disruptive change by fusing global experience with local information from
experts throughout the world. We bring context to strategic and tactical data
by bridging approaches based on data science and field research, assisting you
in addressing your most pressing problems and spotting possibilities.
Contact
Us:
Akash
Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone:
+1-415-230-0044 (US) | +91-7798602273 (IND),
Website:
https://www.snsinsider.com/
Comments
Post a Comment